Ethosuximide Screen, Serum/Plasma Test (9171SP)

Ethosuximide Screen, Serum/Plasma Test (9171SP)

Analysis Code 9171SP 
Test Name Ethosuximide Screen, Serum/Plasma 
Test Includes Ethosuximide 
Compound Synonym(s) Zarontin┬« 
Purpose Exclusion Screen; This test is New York State approved. 
Category Anticonvulsant, Antiepileptic 
Method(s) Gas Chromatography (GC) 
Specimen Requirements 2 mL Serum or Plasma 
Transport Temperature Frozen 
Specimen Container Plastic container (preservative-free) 
Special Handling Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. 
Light Protection Required Not Required 
Stability Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 ┬░C): 9 month(s) 
*Rejection Criteria Polymer gel separation tube (SST or PST). 
Day(s) Test Set-up / TAT [GC] Monday / 3 days 
Suggested CPT Code 80307 
**Minimum Volume 0.6 mL 
Reflex Testing
(when required, addl' fee may apply)
5517SP - Ethosuximide Confirmation, Serum/Plasma 
Test Summary Sheet Generate  

You are viewing Ethosuximide Screen, Serum/Plasma Test (9171SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9